Towards Transformative Therapies for Sickle Cell Disease (SCD) 2017

Towards Transformative Therapies for Sickle Cell Disease is organized by New York Academy of Sciences and would be held on Oct 24, 2017 at The New York Academy of Sciences, New York, United States of America.

Course Description :
Sickle Cell Disease (SCD) is a debilitating blood disorder with high mortality rates, yet to date only a single therapy for the disease has been approved by the FDA. Markedly, improved insight into the complex pathophysiology of SCD has led to the recent development of diverse approaches for treatment, including inhibition of hemoglobin polymerization, prevention and treatment of vaso-occlusive events, and disease corrective gene therapy approaches. This symposium will discuss these recent developments highlighting key biological mechanisms of disease and reviewing relevant clinical science around SCD, while underscoring the importance of the patient experience.

Additional Details will be posted as soon as they are available.